Prevalence of Congenital Cytomegalovirus Infection in Symptomatic Newborns Under 3 weeks in Tehran, Iran

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2017 Oct 20

PMID 29047343

Citations 3

Authors

Mina Ebrahimi-Rad

Talayeh Seyed Shakeri

Fariba Shirvani

Kiana Shahrokhi

Nader Shahrokhi

Affiliations

Soon will be listed here.

Abstract

Background: Cytomegalovirus (CMV) is a common cause of congenital infection worldwide and infants with symptomatic congenital CMV (cCMV) infection are at significantly increased risk of developing adverse long-term outcomes. This study aimed to determine the prevalence of cCMV infections in symptomatic infants under 3 weeks in Tehran, IRAN and to evaluate the usefulness of serologic markers in these neonates.

Methods: Urine and serum samples of 100 symptomatic infants, under 3 weeks old, with clinical signs referred to Tehran medical centers from June 2013 to December 2014, were collected and tested for CMV-DNA and IgG/IgM antibody titers by PCR and ELISA, respectively.

Results: CMV-DNA was detected in urine of 58 cases, whereas only 20 cases had detectable CMV-IgM titers. All CMV-IgM positive cases excreted CMV-DNA through their urine. Of the 100 patients, only 59 had CMV-IgG antibody and CMV-DNA was found in the urine of only 40 of them.

Conclusions: We conclude that CMV is an important etiologic agent of congenital infections in symptomatic infants in Tehran, IRAN (prevalence: 58%) and CMV-DNA detection immediately after delivery is recommended for early treatment and reduction of post infection problems. Furthermore, our study showed that the serologic markers are unreliable for diagnosis of cCMV infection in infants. This is the first report of cCMV prevalence in symptomatic congenital infections in Iran showing similarity with the world averages.

Citing Articles

Congenital cytomegalovirus infection in newborns suspected of congenital rubella syndrome in Iran: a cross-sectional study.

Mirsalehi N, Yavarian J, Ghavami N, Naseri M, Khodakhah F, Shatizadeh Malekshahi S BMC Pediatr. 2024; 24(1):31.

PMID: 38200453 PMC: 10777647. DOI: 10.1186/s12887-023-04502-3.

Frequency of congenital cytomegalovirus infections in newborns in the Sao Paulo State, 2010-2018.

Figueiredo C, Luchs A, Durigon E, de Oliveira D, Silva V, Mello R Rev Inst Med Trop Sao Paulo. 2020; 62:e54.

PMID: 32756824 PMC: 7458071. DOI: 10.1590/s1678-9946202062054.

The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review.

Al Mana H, Yassine H, Younes N, Al-Mohannadi A, Al-Sadeq D, Alhababi D Pathogens. 2019; 8(4).

PMID: 31683687 PMC: 6963600. DOI: 10.3390/pathogens8040213.

References

Yamaguchi A, Oh-Ishi T, Arai T, Sakata H, Adachi N, Asanuma S . Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study. BMJ Open. 2017; 7(1):e013810. PMC: 5253530. DOI: 10.1136/bmjopen-2016-013810. View

Bissinger A, Sinzger C, Kaiserling E, Jahn G . Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol. 2002; 67(2):200-6. DOI: 10.1002/jmv.2208. View

Mussi-Pinhata M, Yamamoto A, Moura Brito R, Isaac M, de Carvalho e Oliveira P, Boppana S . Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis. 2009; 49(4):522-8. PMC: 2778219. DOI: 10.1086/600882. View

Albanna E, El-Latif R, Sharaf H, Gohar M, Ibrahim B . Diagnosis of congenital cytomegalovirus infection in high risk neonates. Mediterr J Hematol Infect Dis. 2013; 5(1):e2013049. PMC: 3736879. DOI: 10.4084/MJHID.2013.049. View

Kanda Y, Chiba S, Suzuki T, Kami M, Yazaki Y, Hirai H . Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation. Br J Haematol. 1998; 100(1):222-5. DOI: 10.1046/j.1365-2141.1998.00518.x. View

Rasmussen L, Kelsall D, Nelson R, Carney W, Hirsch M, Winston D . Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis. 1982; 145(2):191-9. DOI: 10.1093/infdis/145.2.191. View

Boivin G, Handfield J, Toma E, Lalonde R, Bergeron M . Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. J Infect Dis. 1999; 179(5):1101-7. DOI: 10.1086/314721. View

Priya K, Madhavan H . Diagnostic value of enzyme linked immuno-sorbent assay for cytomegalovirus disease. J Postgrad Med. 2002; 48(3):176-8; discussion 190. View

Bhatia J, Shah B, Mehta A, Deshmukh M, Sirsat R, Rodrigues C . Comparing serology, antigenemia assay and polymerase chain reaction for the diagnosis of cytomegalovirus infection in renal transplant patients. J Assoc Physicians India. 2005; 52:297-300. View

10.

McCarthy M, Auger D, Whittemore S . Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J Hum Virol. 2000; 3(4):215-28. View

11.

Fowler K, Stagno S, Pass R . Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis. 1993; 168(3):552-6. DOI: 10.1093/infdis/168.3.552. View

12.

Boppana S, Ross S, Shimamura M, Palmer A, Ahmed A, Michaels M . Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011; 364(22):2111-8. PMC: 3153859. DOI: 10.1056/NEJMoa1006561. View

13.

Belec L, Brogan T . Real-time PCR-based testing of saliva for cytomegalovirus at birth. Expert Rev Anti Infect Ther. 2011; 9(12):1119-24. DOI: 10.1586/eri.11.130. View

14.

Boppana S, Fowler K, Britt W, Stagno S, Pass R . Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999; 104(1 Pt 1):55-60. DOI: 10.1542/peds.104.1.55. View

15.

Pillet S, Roblin X, Cornillon J, Mariat C, Pozzetto B . Quantification of cytomegalovirus viral load. Expert Rev Anti Infect Ther. 2013; 12(2):193-210. DOI: 10.1586/14787210.2014.870887. View

16.

Bello C, Whittle H . Cytomegalovirus infection in Gambian mothers and their babies. J Clin Pathol. 1991; 44(5):366-9. PMC: 496863. DOI: 10.1136/jcp.44.5.366. View

17.

Marin L, de Carvalho Cardoso E, Bispo Sousa S, Carvalho L, Marques Filho M, Raiol M . Prevalence and clinical aspects of CMV congenital Infection in a low-income population. Virol J. 2016; 13:148. PMC: 5006363. DOI: 10.1186/s12985-016-0604-5. View

18.

Revello M, Lilleri D, Zavattoni M, Furione M, Middeldorp J, Gerna G . Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. J Clin Microbiol. 2003; 41(4):1772-4. PMC: 153931. DOI: 10.1128/JCM.41.4.1772-1774.2003. View

19.

Vauloup-Fellous C, Ducroux A, Couloigner V, Marlin S, Picone O, Galimand J . Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol. 2007; 45(11):3804-6. PMC: 2168533. DOI: 10.1128/JCM.01654-07. View

20.

Miura C, Miura E, Mombach A, Chesky M . The prevalence of congenital cytomegalovirus infection in newborn infants at an intensive care unit in a public hospital. J Pediatr (Rio J). 2006; 82(1):46-50. DOI: 10.2223/JPED.1436. View